Dr Agarwal's Eye Hospital Merger Takes Effect From November 1

Dr Agarwal's Health Care Ltd (AHCL) stated on Tuesday that its amalgamation scheme involving Dr Agarwal's Eye Hospital Ltd (AEHL) became operative on November 1, 2026, following an order from the National Company Law Tribunal (NCLT) Chennai Bench dated September 30, 2026, according to Hindu BusinessLine. The board set Wednesday, November 18, 2026, as the record date to identify eligible AEHL shareholders who will receive AHCL shares under the merger, Hindu BusinessLine reported.
Share Exchange Ratio and Leadership
Under the approved swap ratio, eligible AEHL investors are allotted 23 AHCL equity shares of Re 1 face value per 2 AEHL shares of Rs 10 face value held, according to Hindu BusinessLine. The merger brings both listed entities under Dr Agarwal's Health Care Ltd to simplify the group's corporate structure and align investments across hospitals, clinical capabilities, technology, and talent, Hindu BusinessLine reported. Following the merger, Dr Amar Agarwal was appointed by the board as Executive Chairman and Whole-Time Director from November 1, scanx.trade reported.
Q2FY27 Financial Results and Expansion
For the quarter ended September 30, 2026 (Q2FY27), AHCL posted a 90.8% year-on-year rise in standalone net profit to Rs 43.5 crore on standalone revenue of Rs 560 crore, up 31.1%, while consolidated revenue reached a record Rs 655 crore, up 31.4%, according to scanx.trade. Consolidated EBITDA grew 28.8%, and same-store sales growth stood at 18.8% in Q2FY27 and 17.7% in H1FY27, with services contributing 78.0% of quarterly revenue and product sales 22.0%, scanx.trade reported. Operating 324 facilities as of September 30 (305 in India and 19 in Africa), the company raised its FY27 expansion target to 65 new facilities and completed a Rs 55 crore acquisition of two tertiary care centres in Delhi NCR, scanx.trade reported, adding that rapid expansion shifted the balance sheet from Rs 215 crore net cash in Q2FY26 to Rs 29 crore net debt in Q2FY27. In Q2FY27, AHCL opened 21 new centres and added 39 facilities during H1FY27, while management said on its November 5 earnings call that its 65-facility FY27 target includes 55 surgical centres, scanx.trade reported. The North region contributed 9% of group revenue with 60% year-on-year growth as the Delhi NCR network reached 15 facilities, and Hindu BusinessLine noted the unified structure gives investors a clearer view of the combined group. Surgical volumes remained a key growth driver across the eye-care network, scanx.trade reported.
Background
In H1 FY27, the group served over 18.4 lakh patients (+28.5% YoY), according to multibagg.ai.
In FY26, AHCL's revenue grew by 21.57% YoY to Rs 2,080.08 crore as it commissioned 57 new facilities across 26 new cities, according to icicidirect.com.
Dr. Agarwal's Health Care's Rs 3,027 crore IPO was priced at Rs 402 per share and listed on the NSE on February 4, 2025, according to yourarmor.ai.
Management raised planned FY27 capital expenditure to Rs 500 crore from about Rs 400 crore and scheduled 26 new facilities (including 21 surgical facilities) for H2 FY27, according to multibagg.ai.
Following the October 15, 2026 RoC Chennai filing (Appointed Date April 1, 2026), AEHL's authorized share capital of 20 crore Re 1 shares is reclassified and combined with AHCL, increasing AHCL's total authorized capital to Rs 110 crore, according to steelcitynettrade.com.
